Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-10T15:02:46.756Z Has data issue: false hasContentIssue false
  • English
  • Français

DNA-damage response pathways triggered by viral replication

Published online by Cambridge University Press:  03 March 2006

Alison Sinclair ,
Sarah Yarranton  and
Celine Schelcher
Alison Sinclair
Affiliation:
School of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK.
Sarah Yarranton
Affiliation:
School of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK.
Celine Schelcher
Affiliation:
School of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

Many viruses, with distinct replication strategies, activate DNA-damage response pathways, including the lentivirus human immunodeficiency virus (HIV) and the DNA viruses Epstein–Barr virus (EBV), herpes simplex virus 1, adenovirus and SV40. DNA-damage response pathways involving DNA-dependent protein kinase, ataxia-telengiectasia mutated (ATM) and ‘ataxia-telengiectasia and Rad3-related’ (ATR) have all been implicated. This review focuses on the effects of HIV and EBV replication on DNA repair pathways. It has been suggested that activation of cellular DNA repair and recombination enzymes is beneficial for viral replication, as illustrated by the ability of suppressors of the ATM and ATR family to inhibit HIV replication. However, activation of DNA-damage response pathways can also promote apoptosis. Viruses can tailor the cellular response by suppressing downstream signalling from DNA-damage sensors, as exemplified by EBV. New small-molecule inhibitors of the DNA-damage response pathways could therefore be of value to treat viral infections.

Keywords

HIVEBVDNA-damagerepairATMATR
Type
Review Article
Information
Expert Reviews in Molecular Medicine , Volume 8 , Issue 5 , 6 March 2006 , pp. 1 - 11
Copyright
Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)